INTRODUCTION
It is generally accepted that increased consumption of n-3 fatty acids lowers the risk of 48 cardiovascular disease (De Caterina 2011) . The main source of n-3 fatty acids in the Western 135 malleolus. The sensory nerve conduction velocity was calculated by measuring the latency to 136 the onset/peak of the initial negative deflection and the distance between stimulating and 137 recording electrodes. The motor and sensory nerve conduction velocity was reported in meters 138 per second.
139
Corneal innervation: Subbasal corneal nerves were imaged using the Rostock cornea 140 module of the Heidelberg Retina Tomograph confocal microscope as previously described 141 (Davidson et al. 2012 ). The anesthetized rat was secured to a platform that allows adjustment 142 and positioning of the rat in three dimensions. A drop of GenTeal (lubricant eye gel) was 143 applied onto the tip of the lens and advanced slowly forward until the gel contacted the cornea 144 allowing optical but not physical contact between the objective lens and corneal epithelium 145 (Davidson et al. 2012) . Six random high-quality images without overlap of the sub-epithelial 146 nerve plexus around the perimeter of the central cornea were acquired by finely focusing the 147 objective lens to maximally resolve the nerve layer just under the corneal epithelium. The 148 investigator acquiring these images was masked with respect to identity of the animal condition.
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For these studies a single parameter of corneal innervation was quantified. Corneal nerve fiber 150 length defined as the total length of all nerve fibers and branches (in millimeters) present in the 151 acquired image standardized for area of the image (in square millimeters) was determined for 152 each image by tracing the length of each nerve in the image, summing the total length and 153 dividing by the image area (Davidson et al. 2012) . The corneal fiber length for each animal was 154 the mean value obtained from the six acquired images and expressed as mm/mm 2 . Based on 155 receiver operating characteristic (ROC) curve analysis corneal nerve fiber length is the optimal 156 parameter for diagnosing patients with diabetic neuropathy and has the lowest coefficient of 157 variation (Quattrini et al. 2007; Tavakoli et al. 2010 ).
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After completion of all in vivo analyses corneas were dissected from the eyes and trimmed 160 around the scleral-limbal region as previously described (Yorek et al. 2014) . The cornea was 161 fixed for 1h in 2% paraformaldehyde in phosphate-buffered saline. The tissue was blocked with 162 0.2% Triton X-100 and 1% bovine serum albumin (BSA) for 1h, and then permeabilized in 10%
163
Triton X-100 and 1% bovine serum albumin for 1h. The cornea was then incubated with 164 neuronal class III β-anti-tubulin 1:500 in incubation buffer overnight at 4 o C (Covance, Dedham, 165 MA). After washing with incubation buffer, the tissue was incubated with Alexa Fluor 546 goat 166 anti-rabbit IgG 1:2000 in incubation buffer for 2 hours at room temperature (Invitrogen, Eugene, 167 OR). After washing, the cornea was placed epithelium up on a microscope slide. Excess water 168 was carefully aspirated and three radial cuts were made at 120 degree intervals, nearly to the 169 center of the cornea. The tissue was carefully covered with a cover slip, mounted with ProLong
170
Gold and sealed with clear nail polish. A 3x3 matrix of Z-stack images were collected using a 171 Zeiss LM710 confocal microscope with ZEN Black software. An analysis of corneal nerve 172 images was completed with Imaris software version 7.6.4 X64 (Bitplane, Zurich, Switzerland).
173
For epithelial corneal nerves to determine the total surface area covered by corneal innervation a two-dimensional surface was rendered on the fluorescent staining of a maximum projection 175 image. The measurements are reported as a percentage of total area.
176
Intraepidermal nerve fiber density in the hindpaw: Immunoreactive intraepidermal nerve 177 fiber profiles, which are primarily sensory nerves, were visualized using confocal microscopy.
178
Samples of skin of the right hindpaw were fixed, dehydrated and embedded in paraffin.
179
Sections (7 µm) were collected and immuno stained with anti-PGP9.5 antibody (rabbit anti 180 human, AbD Serotic, Morpho Sys US Inc., Raleigh, NC) overnight followed by treatment with 181 secondary antibody Alexa Fluor 546 goat anti rabbit (Invitrogen, Eugene, OR). Profiles were 182 counted by two individual investigators that were masked to the sample identity. All 183 immunoreactive profiles within the epidermis were counted and normalized to epidermal length 184 (Davidson et al. 2010 (Davidson et al. , 2012 .
185
Biological and oxidative stress markers: Non-fasting blood glucose was determined.
186
Hemoglobin A 1 C levels were determined using a Glyco-tek affinity column kit (Helena 187 Laboratories, Beaumont, TX). Serum samples were collected for determination of free fatty 188 acid, triglyceride and free cholesterol using commercial kits from Roche Diagnostics, Mannheim,
189
Germany; Sigma Chemical Co., St. Louis, MO; and Bio Vision, Mountain View, CA, respectively.
190
Serum samples were also collected for analysis of fatty acid composition. Lipids were extracted 191 from diets and serum with a 2:1 (vol/vol) mixture of chloroform and methanol followed by phase 192 separation with a solution of 154 mM NaCl and 4 mM HCl. Fatty acid composition were 193 measured after the lipid fraction was trans esterified in 14% boron trifluoride in methanol and the 194 fatty acid methyl esters extracted into heptane before separation by gas-liquid chromatography 195 (Yorek et al. 1984a (Yorek et al. , 1984b . Individual fatty acids peaks as % of total fatty acids present were 196 identified by comparison to known fatty acid standards. 
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Effect of type 1 diabetes duration 4-12 weeks on neuropathy. Table 2 present data for 206 the progression of diabetic neuropathy over the period of 4-12 weeks after the induction of 207 hyperglycemia in 12 week old rats. From 4 to 12 weeks hemoglobin A 1 C levels trended to 208 increase. Both motor and sensory nerve conduction velocities were significantly decreased 209 compared to control rats after 4 weeks of diabetes. Diabetic rats were thermal hypoalgesic after 210 8 weeks of hyperglycemia. In this study after 4 weeks of diabetes we did not observe any 211 indication of thermal hyperalgesia. In the cornea a significant decrease of sub-epithelial corneal 212 nerves was detected using corneal confocal microscopy after 8 weeks of diabetes and a 213 significant decrease in cornea sensitivity was detected using a Cochet-Bonnet filament 214 esthesiometer after 12 weeks of diabetes. Based on these results we chose the time frame for 215 the intervention protocol to be 8 weeks of non-treated diabetes followed by 8 weeks of 216 treatment.
217
Effect of type 1 diabetes and dietary treatment with menhaden oil on serum fatty acid 218 composition. Data in Table 3 show the fatty acid composition of the serum of control rats 219 treated with or without menhaden oil, non-treated diabetic rats and diabetic rats treated with 220 menhaden oil following a prevention or intervention protocol. Compared to serum from control 221 rats there is little change in the fatty acid composition in the serum from diabetic rats. Treating 222 control rats for 16 weeks with menhaden oil caused a significant decrease in oleic acid, linoleic 223 acid and arachidonic acid in the serum and a significant increase in eicosapentaenoic acid and 224 docosahexaenoic acid compared to control rats. Treating diabetic rats with menhaden oil 225 caused a significant decrease in stearic acid, linoleic acid and arachidonic acid in the serum and 226 a significant increase in eicosapentaenoic acid and docosahexaenoic acid compared to control 227 or non-treated diabetic rats. There was no difference in the fatty acid composition of serum in 228 diabetic rats treated with menhaden oil for 8 (intervention) or 16 (prevention) weeks. As expected the fatty acid unsaturation index was significantly increased in serum from control or 230 diabetic rats treated with menhaden oil compared to control or non-treated diabetic rats (Table   231 3). The n-6 to n-3 fatty acid ratios in serum from control, control + menhaden oil, non-treated 232 diabetic, diabetic + menhaden oil (prevention) and diabetic + menhaden oil (intervention) rats 233 was 16.3 ± 1.2, 1.5 ± 0.1, 14.2 ± 1.9, 1.5 ± 0.1 and 1.8 ± 0.1, respectively.
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Effect of type 1 diabetes and dietary treatment with menhaden oil on weight, blood 235 glucose and serum lipid levels. Data in Table 4 demonstrate that non-treated and treated 236 diabetic rats failed to gain weight compared to control rats. Control rats fed the menhaden oil 237 enriched diet trended to gain more weight than control rats but the difference in the final weight 238 was not significant. Blood glucose and hemoglobin A 1 C values were significantly increased in 239 non-treated diabetic rats and treating diabetic rats with menhaden oil did not significantly affect 240 the hyperglycemic state. Serum triglycerides, free fatty acids and cholesterol were all 241 significantly increased in non-treated and treated diabetic rats. Treating control rats with 242 menhaden oil did not affect blood glucose or serum lipid levels.
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Effect of type 1 diabetes and dietary treatment with menhaden oil on nerve conduction 244 velocity, thermal nociception, tactile response and intraepidermal nerve fiber density. Motor and 245 sensory nerve conduction velocity was significantly decreased non-treated diabetic rats 246 compared to control rats (Figure 1 ). Treating diabetic rats using a prevention or intervention 247 protocol with a high fat diet enriched with menhaden oil significantly improved motor and 248 sensory nerve conduction velocity compared to non-treated diabetic rats although motor nerve 249 conduction velocity in diabetic rats treated with menhaden oil remained significantly decreased 250 compared to control rats. Treating control rats with menhaden oil did not affect motor or 251 sensory nerve conduction velocity. Data in Figure 2 demonstrate that non-treated diabetic rats 252 are hypoalgesic to thermal stimuli compared to control rats and this was significantly improved 253 when diabetic rats were treated using either a prevention or intervention protocol with a high fat 254 diet enriched with menhaden oil. Tactile response threshold was significantly decreased in non-treated diabetic rats ( Figure 2 ). Treating diabetic rats with a diet enriched with menhaden oil 256 using a prevention protocol significantly improved the tactile response. The tactile response in 257 diabetic rats treated with dietary menhaden oil using an intervention protocol was also improved 258 but to a lesser extent than observed using the prevention protocol. Treating control rats with a 259 diet enriched with menhaden oil did not affect thermal or tactile responses ( Figure 2 ).
260
Intraepidermal nerve fiber profiles in the hindpaw of non-treated diabetic rats were significantly 
DISCUSSION

282
The goal of these studies was to determine whether enriching the diet of type 1 diabetic 283 rats with menhaden oil, a natural source of n-3 fatty acids, improves diabetic neuropathic 284 endpoints. Fish oils are a common dietary supplement used for a variety of conditions including 285 cardiovascular health and could be easily translated to clinical trials for diabetic peripheral 286 neuropathy. Some of the unique features of this study were that we used 16 week duration for 287 diabetes and incorporated both a prevention and intervention protocol into the study design with 288 initiation of the intervention protocol beginning after neuropathology had developed. The 289 hypothesis being tested was that treatment of diabetic rats with a source of n-3 fatty acids will 290 promote a decrease in the n-6/n-3 fatty acid ratio, a sign of reduced inflammatory stress, leading 
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The major findings from this study were that the development of diabetic neuropathology 300 endpoints examined appeared at different times over the duration of 4-12 weeks of non-treated 301 diabetes. Reduction in motor and sensory nerve conduction velocity was the first deficit to 302 appear after 4 weeks of diabetes. Impairment of functional and structural deficits in the skin and 
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The serum fatty acid profile was not significantly different between control and diabetic 309 rats. However, after 8-16 weeks of treatment with menhaden oil both control and diabetic rats 310 had a significantly different serum fatty acid profile compared to untreated rats and reflects a 311 new steady state with higher levels of the n-3 fatty acids eicosapentaenoic and 312 docosahexaenoic acids. With higher levels of n-3 fatty acids accounting for a greater 313 percentage of the fatty acids in serum there was a significant decrease in oleic, linoleic and 314 arachidonic acids in control rats treated with menhaden oil compared to untreated control rats 315 and a significant decrease in stearic, linoleic and arachidonic acids in diabetic rats treated with 316 menhaden oil compared to untreated diabetic rats. Notable differences between control and 317 diabetic rats treated with menhaden oil were that levels of oleic acid in serum of diabetic rats 318 were significantly higher in diabetic rats compared to control rats treated with menhaden oil and 319 levels of arachidonic acid in control rats treated with menhaden oil were significantly higher 320 compared to diabetic rats treated with menhaden oil. The reason for these differences are not 321 entirely clear but it appears that treating diabetic rats with menhaden oil tended to maintain 322 levels of oleic acid in the serum at the expense of arachidonic acid. These changes in the 323 serum fatty acid composition with menhaden oil treatment of diabetic rats resulted in a 324 significant lowering of the n-6 to n-3 fatty acid ratio. Lowering of the n-6 to n-3 fatty acid ratio is 325 a marker for reduction in inflammatory stress and could partially explain some of the beneficial 326 effects of enriching the diet with menhaden oil on diabetic neuropathy. This suggests that the 327 potential for inflammatory mediators being produced are significantly reduced in diabetic rats fed Omran 2012). Vascular dysfunction is thought to be a contributing factor to diabetic neuropathy 346 and we have previously demonstrated that impaired vascular relaxation to acetylcholine by 347 epineurial arterioles, blood vessels that supply the sciatic nerve, precedes slowing of nerve 348 conduction velocity (Coppey et al. 2000) . In this study we did not determine the effect of 349 menhaden oil on vascular function or blood flow, a goal for future studies. However, we 350 previously demonstrated that treating diet induced obese mice with menhaden oil corrected 
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In the current study we found that enrichment of the diet with menhaden oil of a rat 374 model of type 1 diabetes improved endpoints associated with diabetic neuropathy. Our study 375 did not address the mechanism(s) that may be responsible for the beneficial effects of 376 menhaden oil on diabetic neuropathy. However, it is possible that enriching the diet of diabetic 377 rats with menhaden oil contributed to an increase in resolvin and neuroprotectin D1 production 378 and neural protection/regeneration. Future studies will examine the effect menhaden oil 379 supplementation has on reducing inflammatory stress and promoting the formation of 380 neuroprotective compounds such as resolvins and neuroprotectin D1.
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In summary, we have demonstrated that dietary enrichment with menhaden oil, a natural source 382 of n-3 fatty acids, in a rat model for type 1 diabetes prevented, but more importantly reversed, 383 numerous pathological endpoints associated with diabetic neuropathy. These results are in 384 agreement with previous studies performed with a type1 and 2 diabetic rat models (Coppey et 385 al. 2012; Gerbi et al. 1999) . This suggests that dietary enrichment with n-3 fatty acids may be 386 beneficial treatment for diabetic peripheral neuropathy. week (6) Diabetic 4 week (6) Control 8 week (6) Diabetic 8 week (6) Control 12 week (6) Diabetic 12 week (5) Start weight (g) 293 ± 5 300 ± 4 295 ± 3 306 ± 4 297 ± 3 296 ± 3 
